Clinical Trials in Denver

Showing 8321-8340 of 18,161 trials

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

NCT04565249

Evaluation of the safety, tolerability, and pharmacokinetics of PLN-74809 in participants with acute respiratory distress syndrome (ARDS) associated with at least severe COVID-19

Acute Respiratory Distress SyndromeSARS-CoV-2

Pliant Therapeutics, Inc.6 participantsStarted Oct 2020

Phoenix, Arizona, United States • Los Angeles, California, United States • Denver, Colorado, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients

NCT01568866

The primary objective of this study was to compare progression-free survival in patients with multiple myeloma who relapsed after 1 to 3 prior therapies treated with carfilzomib plus dexamethasone or bortezomib plus dexamethasone.

Multiple Myeloma

Amgen929 participantsStarted Jun 2012

Burbank, California, United States • La Jolla, California, United States • Los Angeles, California, United States +238 more locations

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients

Find Trials by Condition in Denver

A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma

Asthma and Obesity: Pilot Study

LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis

TruGraf® Long-term Clinical Outcomes Study

Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma

A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients

MIMICS-3D-USA Registry Study

A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo

Predictive Assay for Decision Making in Adjuvant Therapy

A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Sotrovimab Expanded Access Treatment Protocol (COVID-19)

OPEN & ASK: Improving Patient-Centered Communication in Primary Care

CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease

Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury